Anti-Angiogenesis Drug Discovery and Development
Volume 2
- Publisher's listprice EUR 71.95
-
29 841 Ft (28 420 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 2 984 Ft off)
- Discounted price 26 857 Ft (25 578 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
29 841 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 3 June 2015
- ISBN 9780128039632
- Binding Paperback
- No. of pages326 pages
- Size 234x190 mm
- Weight 680 g
- Language English 0
Categories
Long description:
The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, and more. Efforts to understand the molecular basis, both for inhibition and induction, have yielded fascinating results.
Originally published by Bentham and now distributed by Elsevier, Anti-Angiogenesis Drug Discovery and Development, Volume 2 is an compilation of well-written reviews on various aspects of the anti-angiogenesis process. These reviews have been contributed by leading practitioners in drug discovery science and highlight the major developments in this exciting field in the last two decades. These reader-friendly chapters cover topics of great scientific importance, many of which are considered significant medical breakthroughs, making this book excellent reading both for the novice as well as for expert medicinal chemists and clinicians.
MoreTable of Contents:
1. Mechanism of Controlling Blood Vessel Growth and Development and Identification of Therapeutics Against Pathological Angiogenesis
2. Development of In Vitro Method for Assaying Anti-Angiogenic Effect of Drugs
3. Clear Cell Renal Cell Carcinoma as a Model of Pathological Angiogenesis: Which Actors to Target for Treatment?
4. Inhibition of Angiogenesis in Cancer Management by Antioxidants: Ascorbate and P. leucotomos
5. Development of Novel Anti-Cancer Strategies Based on Angiogenesis Inhibition
6. Discovery and Development of Antiangiogenetic Drugs in Ovarian Cancer
7. STAT3 Signaling in Cancer: Small Molecule Intervention as Therapy?
8. Anti-Angiogenic Therapy and Cardiovascular Diseases: Current Strategies and Future Perspectives
